Data from this study demonstrated progressive reductions in estimated glomerular filtration rate (eGFR) over time following initiation of 177 Lu-PSMA-I&T therapy, with trajectories shown separately ...

Increasingly, 177 Lu-PSMA-617 is used for patients with mCRPC, while many of these patients may also require palliative ...

Using baseline clinical data alone, the model incorporated prior treatments, blood-test results, ECOG performance status, PSA ...

Quantitative PSMA uptake was the third prognostic biomarker highlighted, with increasing SUVmean associated with an HR of 1.74. Patients were stratified according to quartiles of SUVmean, with ...

The 2026 ProsTIC annual meeting featured a Lutetium-177 session and a presentation by Dr. Renu Eapen discussing whether there ...

(UroToday.com) The 2026 ProsTIC annual meeting featured a PSMA imaging session and a presentation by Dr. Sidney Levy ...

Dr. Eiber then outlined why standardized reporting is particularly important for PSMA PET. From a clinical perspective, ...

(UroToday.com) The 2026 ProsTIC annual meeting featured a Lutetium-177 session and a presentation by Dr. Arun Azad discussing ...

She earned her MSN from Rush University Medical Center College of Nursing and holds advanced oncology nurse practitioner certification through the Oncology Nursing Certification Corporation. Brenda ...

Despite Bacillus Calmette-Guerin (BCG) remaining the standard of care for high-risk non-muscle-invasive bladder cancer (HR-NMIBC), novel combination strategies are being actively investigated.

Following completion of the 2025 Update Literature Review (ULR), the American Urological Association (AUA) incorporated new evidence generated since the 2023 publication of this Guideline via the AUA ...

Androgen receptor signaling inhibitors (ARSI) and docetaxel (DTX) are standard treatments for metastatic castration-resistant prostate cancer (mCRPC). However, the differences in therapeutic efficacy ...